Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study
Crossref DOI link: https://doi.org/10.1007/s00774-015-0717-8
Published Online: 2015-10-13
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nakano, Tetsuo
Yamamoto, Masao
Hashimoto, Junko
Tobinai, Masato
Yoshida, Seitaro
Nakamura, Toshitaka
Text and Data Mining valid from 2015-10-13